Chloramphenicol
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00446 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 43 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | conjunctivitis | KG + DL |
| 2 | diffuse scleroderma | KG + DL |
| 3 | postinfectious vasculitis | KG + DL |
| 4 | post-bacterial disorder | KG + DL |
| 5 | post-infectious syndrome | KG + DL |
| 6 | infective urethral stricture | KG + DL |
| 7 | Chagas cardiomyopathy | KG + DL |
| 8 | infection-related hemolytic uremic syndrome | KG + DL |
| 9 | punctate epithelial keratoconjunctivitis | KG + DL |
| 10 | chronic rhinosinusitis | KG + DL |
| 11 | chronic ethmoidal sinusitis | KG + DL |
| 12 | eosinophilia-myalgia syndrome | KG + DL |
| 13 | paranasal sinus neoplasm (disease) | KG + DL |
| 14 | sinusitis | KG + DL |
| 15 | exposure keratitis | KG + DL |
| 16 | parasitic eyelid infestation | KG + DL |
| 17 | ulcerative blepharitis | KG + DL |
| 18 | noninfectious dermatoses of eyelid | KG + DL |
| 19 | acne (disease) | KG + DL |
| 20 | acute contagious conjunctivitis | KG + DL |
| 21 | infectious otitis interna | KG + DL |
| 22 | blepharoconjunctivitis | KG + DL |
| 23 | membranous glomerulonephritis | KG + DL |
| 24 | bacterial pneumonia | KG + DL |
| 25 | scleroderma, familial progressive | KG + DL |
| 26 | non-human animal disease | KG + DL |
| 27 | necrotizing ulcerative gingivitis | KG + DL |
| 28 | limited scleroderma | KG + DL |
| 29 | myalgia-eosinophilia syndrome associated with tryptophan | KG + DL |
| 30 | lymphogranuloma venereum | KG + DL |
| 31 | creeping myiasis | KG + DL |
| 32 | furuncular myiasis | KG + DL |
| 33 | wound myiasis | KG + DL |
| 34 | myiasis | KG + DL |
| 35 | toxoplasmosis | KG + DL |
| 36 | demodicidosis of sebaceous gland | KG + DL |
| 37 | chronic gingivitis | KG + DL |
| 38 | acute gonococcal cervicitis | KG + DL |
| 39 | listeriosis | KG + DL |
| 40 | actinomycosis | KG + DL |
| 41 | lymphoid system disease | KG + DL |
| 42 | malaria | KG + DL |
| 43 | geniculate herpes zoster | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.